Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
life sciences
national
5
×
national blog main
national top stories
novartis
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
celgene
deals
detroit blog main
detroit top stories
gene therapy
indiana blog main
indiana top stories
new york blog main
new york top stories
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biogen
bristol-myers squibb
car-t
crispr
drug prices
genentech
ipo
What
gene
5
×
therapy
bio
roundup
advanced
drug
access
alnylam’s
alzheimer’s
approval
becker
bff
billions
capacity
car
cell
chemistry
cmc
companies
conference
consistent
consolidation
controls
crispr
deals
devoted
different
disease
dollars
easl
eaton
ensure
fail
falcon
fda
focus
form
healthcare
impact
increases
Language
unset
Current search:
gene
×
biotech
×
national
×
@xconomy.com
3 years ago
FDA Official: New “Playbook” Needed for CMC Reviews of Gene Therapy Products
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More